The St. Clair Catholic District School Board once again showcased its unwavering commitment to community and philanthropy through its outstanding participation in the 2023 Terry Fox School Run. Across the district, schools united in a remarkable display of generosity, raising a total of $36,595.45 in support of cancer research.

The Terry Fox Foundation acknowledged the remarkable efforts of the St. Clair Catholic family of schools, conveying its appreciation for their dedication and leadership in organizing such a successful fundraising campaign. “On behalf of the Terry Fox Foundation, we extend our deepest gratitude to you and the entire family of schools within the St. Clair Catholic District School Board for your exceptional dedication and commitment to the 2023 Terry Fox School Run,” expressed the Foundation in a letter to Director of Education, Scott Johnson. “Thank you for continuing to uphold Terry’s enduring legacy and inspire future generations in the fight against cancer!”

At the heart of this collective effort lies the enduring legacy of Terry Fox, whose courageous Marathon of Hope continues to inspire generations. His remarkable journey, fueled by resilience, empathy, and an unwavering determination to make a difference, resonates deeply with both staff and students alike.

Director of Education, Scott Johnson, expressed heartfelt appreciation to the entire school community, recognizing the profound impact of their collective efforts. “Our students, staff, and parent volunteers have demonstrated remarkable dedication to this cause,” says Mr. Johnson. “Cancer has touched us all, and by upholding Terry Fox’s legacy, we contribute to the ongoing pursuit of a world without this devastating disease.”

Since the inception of Terry Fox school runs, St. Clair Catholic schools have continually demonstrated their steadfast support, contributing over $1.7 million to the Terry Fox Foundation for cancer research. This ongoing commitment underscores the profound impact of collective action in driving meaningful change and advancing the cause of cancer research.